Discover 332 paid clinical trials in Colorado Springs, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 332
FeaturedActive & Responsive
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: Colorado Springs CO, Lincoln NE, Oklahoma City OK,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & Responsive
Effects of Physical and Psychosocial Stress on Functional Hypothalamic Amenorrhea in Exercising Women
for
Amenorrhea Secondary
Location: Colorado Springs CO
Sponsor: University of Colorado, Colorado Springs
Sex: Female
Age: 18 - 35
Code: NCT05967819
Recruiting
Active & Responsive
Timing of Energy Availability on Menstrual Cycle Function
for
Menstrual Irregularity
Location: Colorado Springs CO
Sponsor: University of Colorado, Colorado Springs
Sex: Female
Age: 18 - 40
Code: NCT06471582
Recruiting
Active & Responsive
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
for
Narcolepsy Type 1
Location: Colorado Springs CO, San Antonio TX, Santa Ana CA,
Sponsor: Takeda
Sex: All
Age: 16 - 70
Code: NCT05816382
Phase2, Phase3, Recruiting
Active & Responsive
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
for
ADHD, Anxiety, Generalized Anxiety, Social Anxiety Disorder
Location: Colorado Springs CO, Oklahoma City OK, Wichita Falls TX,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Sex: All
Age: 18 - 65
Code: NCT06973577
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
VTP-1000 in Adults With Celiac Disease
for
Celiac Disease
Location: Colorado Springs CO, West Jordan UT, Austin TX,
Sponsor: Barinthus Biotherapeutics
Sex: All
Age: 18 - 65
Code: NCT06310291
Early_phase1, Recruiting
Active & Responsive
HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease